. 2013 Sep;10(3):258–266. doi: 10.3969/j.issn.1671-5411.2013.03.004

Table 4. Results of meta-regression when analyzed using treatment as covariates for CHADS₂ and CHA₂DS₂-VASc.

Scoring system	Number*	tau2^#	I-squared_res^†	Adj R-square^▴	Treatment		_cons
Scoring system	Number*	tau2^#	I-squared_res^†	Adj R-square^▴	coef.(95%CI)	P	coef.(95%CI)	P
CHADS₂	11	0.007	95.99%	44.45%	0.15 (0.02–0.28)	0.025	–0.63(–0.84 – –0.43)	0.000
CHA₂DS₂-VASc	11	0.029	98.69%	39.63%	0.29 (0.05–0.53)	0.024	–0.89(–1.29 – –0.50)	0.001

*Number of all include studies; ^#REML estimate of between-study variance; ^†% residual variation due to heterogeneity; ^▴Proportion of between-study variance explained.

Table 4. Results of meta-regression when analyzed using treatment as covariates for CHADS2 and CHA2DS2-VASc.

Table 4. Results of meta-regression when analyzed using treatment as covariates for CHADS₂ and CHA₂DS₂-VASc.